Vaccine Efficacy of Outer Membrane Vesicle Vaccines against Neisseria meningitidis serogroup B disease  

Weigan Zhong , Qingwei Huang
Yulin Normal University, Biology Department, Yulin, 537000, P.R. China
Author    Correspondence author
Journal of Vaccine Research, 2014, Vol. 4, No. 2   
Received: 02 Sep., 2014    Accepted: 17 Oct., 2014    Published: 19 Nov., 2014
© 2014 BioPublisher Publishing Platform
This is an open access article published under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

For evaluation of serum bactericidal activity (SBA) as surrogate for the efficacy of outer membrane vesicle (OMV) vaccines against Neisseria meningitidis serogroup B disease, we have reanalyzed data from a randomized double blind placebo-controlled efficacy trial involving 52 000 secondary school students (aged 11–14 years) in Guangxi Province, Southern China (2008–2011). A cohort of the efficacy trial consisting of 680 individuals was selected for immunogenicity studies. An efficacy of 87% was calculated for a 10-month observation period. However, after an observation period of 29 months, the estimated efficacy against group B disease induced by vaccination was 57%. The immunogenicity study showed that the SBA geometric mean titer (GMT) for the vaccines was 2.4 before vaccination and 19.0 six weeks after the second vaccine dose. One year after vaccination the GMT was reduced to 2.8. A separate three-dose study with 304 adolescents showed that with a third dose at 10 months after the second dose (i.e. when cases of disease started to appear) a strong booster response was induced. Ten months after the second dose the SBA was reduced to near pre-immunization level. Following the third dose the SBA geometric mean titer of 2.7 increased to 62.3. One year after the third dose, the GMT was markedly higher than 6 weeks after the second dose (12.6 versus 8.8). Thus, protection after vaccination corresponds with the level of SBA. In order to reach lasting protective levels of SBA in a population, three vaccine doses are probably required. Measurements of SBA are likely to be useful for evaluating various upcoming formulations and improvements of immunization regimens for OMV vaccines.

Serum bactericidal activity; Outer membrane vesicle; Geometric mean titer; Neisseria meningitidis

(The advance publishing of the abstract of this manuscript does not mean final published, the end result whether or not published will depend on the comments of peer reviewers and decision of our editorial board.)
The complete article is available as a Provisional PDF if requested. The fully formatted PDF and HTML versions are in production.
Journal of Vaccine Research
• Volume 4
View Options
Associated material
. Readers' comments
Other articles by authors
. Weigan Zhong
. Qingwei Huang
Related articles
. Serum bactericidal activity
. Outer membrane vesicle
. Geometric mean titer
. Neisseria meningitidis
. Post a comment